ConductOrganoid

Regulatory Evidence

NAM-vs-Animal Concordance Dashboard

How ConductOrganoid features map to OECD TG 426 developmental neurotoxicity endpoints, with published evidence for each mapping.

7

Features Mapped

3

Strong Concordances

10/9

Substance Classes

Evidence:
Module:

Area / Equivalent Diameter

ConductImageStrongPhase 1 Validated

Effect Size

|r| = 0.52–1.00

ConductOrganoid

ConductImage

Phase 1 — Validated

OECD TG 426

Cross-sectional area of brain regions

Sections 43–46

Organoid area reflects tissue growth capacity; ethanol-exposed rat pups show reduced cortical area (Maier et al., 1999); organoid area is reduced by ethanol (Adams et al., 2023).

EthanolVPAMethadoneFentanylMethamphetamine5/9 classes

Solidity

ConductImageStrongPhase 1 Validated

Effect Size

|r| = 0.57–0.67

ConductOrganoid

ConductImage

Phase 1 — Validated

OECD TG 426

Tissue integrity / neuropathological assessment

Section 43

Solidity measures tissue compactness; decreased solidity indicates disintegration/loosening, analogous to tissue degeneration scored in TG 426 neuropathology.

EthanolVPAMethadoneMethamphetamine4/9 classes

Contrast / Texture Homogeneity

ConductImageModeratePhase 1 Validated

Effect Size

|r| = 0.62–0.79

ConductOrganoid

ConductImage

Phase 1 — Validated

OECD TG 426

Cellular architecture / organization

Section 45

Texture features capture local cellular organization; increased contrast / decreased homogeneity indicates disrupted layering, analogous to disorganized cortical architecture in TG 426 histopathology.

EthanolVPAMethadoneCocaineMethamphetamine5/9 classes

Std Intensity / Intensity Range

ConductImageModeratePhase 1 Validated

Effect Size

|r| = 0.93

ConductOrganoid

ConductImage

Phase 1 — Validated

OECD TG 426

Differentiation markers / heterogeneity

Sections 44–45

Intensity heterogeneity reflects differentiation state variation within organoid; analogous to altered marker expression patterns in developing rat brain.

VPAMethadoneBuprenorphineFentanylOxycodoneCocaine6/9 classes

Growth Velocity / Doubling Time

ConductVisionStrongPhase 1 Validated

Effect Size

14.4x / 10.9x / 7.5x fold-change

ConductOrganoid

ConductVision

Phase 1 — Prototype

OECD TG 426

Brain weight / body weight ratio

Sections 41–42

Organoid growth rate is the in vitro analog of brain growth; dose-dependent growth arrest (Yao 2020, methadone) parallels reduced brain weight in exposed rat pups.

EthanolVPAMethadoneFentanylMethamphetamine5/9 classes

Boundary Roughness / Fractal Dimension

ConductTraceEmerging

Effect Size

Proof-of-concept

ConductOrganoid

ConductTrace

Phase 1 — Proof-of-concept

OECD TG 426

Neurite outgrowth / dendritic arborization

Sections 45–46

Boundary roughness in brightfield is a proxy for neurite-producing organoids; smooth boundaries indicate compact organoids with less outgrowth. 8/9 substance classes affect neurite coverage in published studies.

EthanolMethadoneBuprenorphineFentanylNicotineCocaineCannabisMethamphetamine8/9 classes

Burst Rate / Synchrony Index

ConductSignalEmerging

Effect Size

Phase 2 planned

ConductOrganoid

ConductSignal

Phase 2 — Designed

OECD TG 426

Functional neuronal activity / behavioral endpoints

Sections 47–51

MEA electrophysiology in organoids measures functional network activity; substance-disrupted network formation produces altered burst patterns analogous to behavioral deficits in exposed rat pups.

Multiple substance classes1/9 classes

Full Concordance Mapping

Tabular overview of all ConductOrganoid-to-TG 426 mappings

FeatureModuleTG 426 EndpointStrengthSubstancesEffect Size
Area / Equivalent DiameterConductImageCross-sectional area of brain regionsStrong5/9|r| = 0.52–1.00
SolidityConductImageTissue integrity / neuropathological assessmentStrong4/9|r| = 0.57–0.67
Contrast / Texture HomogeneityConductImageCellular architecture / organizationModerate5/9|r| = 0.62–0.79
Std Intensity / Intensity RangeConductImageDifferentiation markers / heterogeneityModerate6/9|r| = 0.93
Growth Velocity / Doubling TimeConductVisionBrain weight / body weight ratioStrong5/914.4x / 10.9x / 7.5x fold-change
Boundary Roughness / Fractal DimensionConductTraceNeurite outgrowth / dendritic arborizationEmerging8/9Proof-of-concept
Burst Rate / Synchrony IndexConductSignalFunctional neuronal activity / behavioral endpointsEmerging1/9Phase 2 planned